Notch Therapeutics Closes $85M Series A Financing

15 Feb, 2021

Notch Therapeutics Closes $85M Series A Financing
Photo by XPS on Unsplash

– Notch Therapeutics is a Vancouver, BC-based biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer.
– Company closed an U.S. $85m Series A financing.
– The round was led by an exclusively healthcare-focused investment fund with participation from existing investors Allogene Therapeutics, Inc., Lumira Ventures, and CCRM Enterprises Holdings Ltd., an affiliate of Centre for Commercialization of Regenerative Medicine (CCRM); along with new investors EcoR1 Capital, Casdin Capital, Samsara BioCapital, and Amplitude Ventures.

Biotechnology Developer Platform Health Care North America
Crunchbase icon

Content report

The following text will be sent to our editors: